StreetInsider.com  7 hrs ago  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sanofi+%28SNY%29+Reports+Stat+of+Rotavirus+Vaccine+Phase+III+in+India/9908124.html for the full story.
The Hindu Business Line  4 hrs ago  Comment 
FiercePharma  7 hrs ago  Comment 
Last week, Sanofi said it stepped forward with overseas bribery allegations in the U.S.: The French drugmaker told the feds it had hired an outside law firm to dive into an anonymous whistleblower's accusations of corruption in the Middle East....
Market Intelligence Center  8 hrs ago  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Sanofi-Aventis (SNY) that includes 6.31% downside protection. Sell one contract of the Dec. '14...
TheStreet.com  Oct 8  Comment 
NEW YORK (TheStreet) -- Shares ofaUnilifea continue to rise, now up 22.52% to $3.21, on momentum from Monday's announcement that the company had signed a 15-year commercial supply agreement with Sanofia . Unilife will become the exclusive...
Motley Fool  Oct 8  Comment 
Unilife stock is among today's top healthcare stocks after announcing a major commercial agreement with a large pharmaceutical company earlier this week. Find out what this news means for shareholders.
SeekingAlpha  Oct 8  Comment 
By The Kumquat: Background (For those of you who already know all there is to know about MannKind (NASDAQ:MNKD), you can skip the background section and go to the analysis section.) Shares in biotechnology company MannKind have been on a...
FiercePharma  Oct 7  Comment 
Now, it's Sanofi digging into potential bribery in the Middle East. The French drugmaker told U.S. officials that it's eyeing allegations from an anonymous whistleblower about improper payments from 2007 to 2012.
SeekingAlpha  Oct 7  Comment 
By Sharon di Stefano: Targeted cancer therapy is a revolution in drug company research, and Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), recent recipient of a notice of allowance from the US Patent and Trademark Office for a new delivery platform,...
Wall Street Journal  Oct 6  Comment 
Sanofi says it told U.S. authorities about allegations of improper payments to health-care professionals in the Mideast and East Africa, joining a lineup of pharmaceutical companies that have faced similar claims.
Motley Fool  Oct 6  Comment 
Sanofi's global dominance over the lucrative diabetes market is facing a serious challenge with the patent expiration of Lantus, the most commonly prescribed insulin in the world. Can MannKind's inhaled insulin product help Sanofi retain its edge?


Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki